₩14450.00
₩-20.00 (-0.14%)
End-of-day quote: 05/13/2024
KOSE:A016580
Whan In Pharm Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2005 | ||
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩230.39B | ₩198.93B | ₩177.78B | ₩171.71B | ₩66.49B | |
| GM % | Gross Margin % |
|
42.95% | 49.59% | 52.52% | 50.38% | 66.56% | |
| OM | Operating Margin |
|
13.10% | 14.99% | 17.59% | 16.55% | 25.59% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩1.95k | ₩1.57k | ₩1.73k | ₩1.53k | ₩694.00 |
| Div. | Dividends |
|
₩300.00 | ₩300.00 | ₩300.00 | ₩300.00 | ₩0.00 | |
| PR % | Payout Ratio % |
|
15.38% | 19.14% | 17.38% | 19.58% | 0 | |
| Sha. | Shares |
|
15.27m | 15.27m | 15.27m | 15.27m | 15.27m | |
| OCF | Operating Cash Flow |
|
₩23.20B | ₩16.85B | ₩35.32B | ₩22.75B | ₩9.25B | |
| FCF | Free Cash Flow |
|
₩15.21B | ₩-50265.10M | ₩32.35B | ₩14.77B | ₩5.84B | |
| FCFS | Free Cash Flow Per Share |
|
₩-542.03 | ₩-1142.42 | ₩2.00k | ₩951.79 | ₩394.64 |
